Literature DB >> 21381014

Anatomic location is a risk factor for atypical and malignant meningiomas.

Ari J Kane1, Michael E Sughrue, Martin J Rutkowski, Gopal Shangari, Shanna Fang, Michael W McDermott, Mitchel S Berger, Andrew T Parsa.   

Abstract

BACKGROUND: Grade II and III meningiomas have higher rates of tumor recurrence than grade I meningiomas after surgery and/or external irradiation. As the utility of noninvasive treatments for brain tumors increases, it is becoming increasingly important to assess the likelihood that a tumor is not benign before treatment initiation. Hence, the authors have reviewed a large series of their patients to determine risk factors for higher-grade pathology, with particular interest paid to tumor location.
METHODS: The authors reviewed 378 patients presenting at their institution from 2000 to 2007 with histologically confirmed meningioma, central pathology grading according to the World Health Organization 2000 guidelines, and tumor location confirmed with preoperative imaging. They performed univariate and multivariate logistic regression on potential risk factors for high-grade pathology.
RESULTS: Risk factors for grade II/III pathology included nonskull base location (2-fold) and male sex (2-fold). Patients with prior surgery had a 3-fold increased incidence of higher-grade meningiomas at presentation at the authors' center. The authors controlled for this referral bias by performing a multivariate regression, and analysis without patients receiving prior treatment. Ninety-seven percent of operations were performed for tumor size and clinical symptoms, whereas <3% were performed for interval growth or features concerning higher-grade pathology.
CONCLUSIONS: Nonskull-base meningiomas, male sex, and prior surgery impart increased risk for grade II or III pathology. This increased risk translates to probable poorer prognosis and increased likelihood of recurrence after treatment. Thus, it is prudent to take these specific variables into consideration in conjunction with the complete clinical presentation when advising patients regarding their prognosis.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 21381014      PMCID: PMC3795515          DOI: 10.1002/cncr.25591

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

1.  WHO grade II and III meningiomas: a study of prognostic factors.

Authors:  Anne Durand; François Labrousse; Anne Jouvet; Luc Bauchet; Michel Kalamaridès; Philippe Menei; Robert Deruty; Jean Jacques Moreau; Michelle Fèvre-Montange; Jacques Guyotat
Journal:  J Neurooncol       Date:  2009-06-27       Impact factor: 4.130

2.  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

Authors:  Manish K Aghi; Bob S Carter; Garth R Cosgrove; Robert G Ojemann; Sepideh Amin-Hanjani; Robert L Martuza; William T Curry; Fred G Barker
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

3.  Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.

Authors:  David Pasquier; Stefan Bijmolt; Theo Veninga; Nicolas Rezvoy; Salvador Villa; Marco Krengli; Damien C Weber; Brigitta G Baumert; Emine Canyilmaz; Deniz Yalman; Ewa Szutowicz; Tzahala Tzuk-Shina; René O Mirimanoff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-04       Impact factor: 7.038

4.  Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.

Authors:  Carl Wibom; Lina Mörén; Mads Aarhus; Per Morten Knappskog; Morten Lund-Johansen; Henrik Antti; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2009-04-07       Impact factor: 4.130

5.  World Health Organization Grades II and III meningiomas are rare in the cranial base and spine.

Authors:  Burak Sade; Ali Chahlavi; Ajit Krishnaney; Sean Nagel; Eugene Choi; Joung H Lee
Journal:  Neurosurgery       Date:  2007-12       Impact factor: 4.654

6.  Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.

Authors:  Lewis A Rosenberg; Richard A Prayson; Joung Lee; Chandana Reddy; Samuel T Chao; Gene H Barnett; Michael A Vogelbaum; John H Suh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-01       Impact factor: 7.038

7.  Risk profile associated with convexity meningioma resection in the modern neurosurgical era.

Authors:  Nader Sanai; Michael E Sughrue; Gopal Shangari; Kenny Chung; Mitchel S Berger; Michael W McDermott
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

8.  Recurrence and regrowth of benign meningiomas.

Authors:  Satoshi Nakasu; Tadateru Fukami; Jyunya Jito; Kazuhiko Nozaki
Journal:  Brain Tumor Pathol       Date:  2009-10-27       Impact factor: 3.298

9.  Radiosurgery as definitive management of intracranial meningiomas.

Authors:  Douglas Kondziolka; David Mathieu; L Dade Lunsford; Juan J Martin; Ricky Madhok; Ajay Niranjan; John C Flickinger
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

10.  Genome wide expression profiling identifies specific deregulated pathways in meningioma.

Authors:  Andreas Keller; Nicole Ludwig; Christina Backes; Bernd F M Romeike; Nicole Comtesse; Wolfram Henn; Wolf-Ingo Steudel; Christian Mawrin; Hans-Peter Lenhof; Eckart Meese
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

View more
  51 in total

1.  Paediatric clear cell meningioma with multiple distant recurrences after presumed intra-operative cell spread.

Authors:  Onno Küster; Jens Schittenhelm; Oliver Schwartz; Richard Meyermann; Martin U Schuhmann
Journal:  Childs Nerv Syst       Date:  2012-01-05       Impact factor: 1.475

2.  The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases.

Authors:  Ruo-Fei Liang; Ying-Jie Xiu; Xiang Wang; Mao Li; Yuan Yang; Qing Mao; Yan-Hui Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.

Authors:  Waseem Masalha; Dieter Henrik Heiland; Pamela Franco; Daniel Delev; Jan Gerrit Haaker; Oliver Schnell; Christian Scheiwe; Juergen Grauvogel
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

4.  Boron Neutron Capture Therapy for High-Grade Skull-Base Meningioma.

Authors:  Koji Takeuchi; Shinji Kawabata; Ryo Hiramatsu; Yoko Matsushita; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-Ichi Miyatake; Toshihiko Kuroiwa
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-03

Review 5.  A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors.

Authors:  Christopher S Graffeo; August R Dietrich; Bartosz Grobelny; Meng Zhang; Judith D Goldberg; John G Golfinos; Richard Lebowitz; David Kleinberg; Dimitris G Placantonakis
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

6.  Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.

Authors:  Pepijn van den Munckhof; Imke Christiaans; Susan B Kenter; Frank Baas; Theo J M Hulsebos
Journal:  Neurogenetics       Date:  2011-10-26       Impact factor: 2.660

7.  A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas.

Authors:  Zhicen Li; Hao Li; Yuming Jiao; Ji Ma; Shuo Wang; Jizong Zhao; Yong Cao
Journal:  Childs Nerv Syst       Date:  2016-10-29       Impact factor: 1.475

8.  WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.

Authors:  Anne Ressel; Susanne Fichte; Michael Brodhun; Steffen K Rosahl; Ruediger Gerlach
Journal:  J Neurooncol       Date:  2019-10-01       Impact factor: 4.130

9.  Clinical features and long-term outcomes of pediatric meningiomas.

Authors:  Jingdian Liu; Kai Zhao; Junwen Wang; Kai Shu
Journal:  Childs Nerv Syst       Date:  2021-07-22       Impact factor: 1.475

10.  Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Authors:  William L Hwang; Ariel E Marciscano; Andrzej Niemierko; Daniel W Kim; Anat O Stemmer-Rachamimov; William T Curry; Fred G Barker; Robert L Martuza; Jay S Loeffler; Kevin S Oh; Helen A Shih; Mykol Larvie
Journal:  Neuro Oncol       Date:  2015-11-22       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.